Frontiers in Neurology

Article	Citations
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains	269
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide	196
Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery	182
Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review	143
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation	128
The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease	115
Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis	110
Cognitive Impairment After COVID-19—A Review on Objective Test Data	107
The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies	106
Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening	103
Deep Convolutional Neural Network-Based Epileptic Electroencephalogram (EEG) Signal Classification	101
Telemedicine and Virtual Reality for Cognitive Rehabilitation: A Roadmap for the COVID-19 Pandemic	100
Surface EMG in Clinical Assessment and Neurorehabilitation: Barriers Limiting Its Use	99
Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis	95
Comorbidity in Multiple Sclerosis	85
Exploring Sphingolipid Implications in Neurodegeneration	83
Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis	81
Clinical and Imaging Markers of Prodromal Parkinson's Disease	79
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management	78
Hemorrhagic Transformation in Ischemic Stroke and the Role of Inflammation	75
Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes	74
Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	74
Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review	73
The Regulation of microRNAs in Alzheimer's Disease	71
The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?	70

Challenges to the Emergence of Telerehabilitation in a Developing Country: A Systematic Review	68
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes	64
Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium	64
Effects of COVID-19 Pandemic Confinement in Patients With Cognitive Impairment	64
The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review	64
Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations	63
Therapeutic Plasticity of Neural Stem Cells	62
Intrinsically Photosensitive Retinal Ganglion Cells of the Human Retina	62
Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient	61
AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis	61
Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)	61
Seizure Diaries and Forecasting With Wearables: Epilepsy Monitoring Outside the Clinic	60
Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients	60
Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities	60
The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder	59
Effects of Probiotics on Depressive or Anxiety Variables in Healthy Participants Under Stress Conditions or With a Depressive or Anxiety Diagnosis: A Meta-Analysis of Randomized Controlled Trials	59
Gut Microbiota in Acute Ischemic Stroke: From Pathophysiology to Therapeutic Implications	59
Analysis and Biophysics of Surface EMG for Physiotherapists and Kinesiologists: Toward a Common Language With Rehabilitation Engineers	59
A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms	59
The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis	59
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study	58
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study	58
Giving Researchers a Headache – Sex and Gender Differences in Migraine	58
Assessment Methods of Post-stroke Gait: A Scoping Review of Technology-Driven Approaches to Gait Characterization and Analysis	57
Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging	57
Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients	57
COVID-19 Dysautonomia	57
The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis	57
Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury	56
A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS	55
The Lighting Environment, Its Metrology, and Non-visual Responses	55
A Contemporary Review of Neurological Sequelae of COVID-19	54
How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS	54
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias	54
Acute Stroke Biomarkers: Are We There Yet?	54
Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic Encephalopathy	54
Accelerating Telemedicine for Cerebral Palsy During the COVID-19 Pandemic and Beyond	54
The Peripheral Immune System and Amyotrophic Lateral Sclerosis	54
Effects of an Innovative Telerehabilitation Intervention for People With Parkinson's Disease on Quality of Life, Motor, and Non-motor Abilities	53
Reducing the Cognitive Footprint of Brain Tumor Surgery	53
Human-Centric Lighting: Foundational Considerations and a Five-Step Design Process	53
Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke	53
Cerebral Small Vessel Disease and Alzheimer's Disease: A Review	52
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma	52
Considering Biological Sex in Traumatic Brain Injury	51
Characteristics and Impact of U.S. Military Blast-Related Mild Traumatic Brain Injury: A Systematic Review	51
A Practical Approach to Managing Patients With Myasthenia Gravis—Opinions and a Review of the Literature	51
Editorial: Non-invasive Brain Stimulation in the Study and Modulation of Metaplasticity in Neurological Disorders	51
COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management	51
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions	51

Novel Treatments in Myasthenia Gravis	50
HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature	50
Parkinson's Disease Remote Patient Monitoring During the COVID-19 Lockdown	50
Tele-Neuro-Rehabilitation in Italy: State of the Art and Future Perspectives	50
Consensus-Based Core Set of Outcome Measures for Clinical Motor Rehabilitation After Stroke—A Delphi Study	50
Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management	49
Behavioral Assessment of Sensory, Motor, Emotion, and Cognition in Rodent Models of Intracerebral Hemorrhage	49
The Frontal Aslant Tract: A Systematic Review for Neurosurgical Applications	49
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature	49
Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis	48
The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science	48
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management	48
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)	48
Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic	48
Post-stroke Cognitive Impairment—Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study	48
Machine Learning in Action: Stroke Diagnosis and Outcome Prediction	47
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis	47
Cognitive and Emotional Disturbances Due to COVID-19: An Exploratory Study in the Rehabilitation Setting	47
Plasma Inflammatory Cytokines Are Elevated in ALS	47
Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets	47
The Multifaceted Role of Astrocyte Connexin 43 in Ischemic Stroke Through Forming Hemichannels and Gap Junctions	47
From Genotype to Phenotype: Expanding the Clinical Spectrum of CACNA1A Variants in the Era of Next Generation Sequencing	47
Retinal Ganglion Cells—Diversity of Cell Types and Clinical Relevance	46
Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis	46
A Systematic Review of Telemedicine for Older Adults With Dementia During COVID-19: An Alternative to In-person Health Services?	46
Hematoma Expansion in Intracerebral Hemorrhage: An Update on Prediction and Treatment	46
The Many Faces of Astrocytes in Alzheimer's Disease	46
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection	46
The Role of Engagement in Teleneurorehabilitation: A Systematic Review	46
Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults	45
Dissecting the Genetic and Etiological Causes of Primary Microcephaly	45
Effects of Microglial Activation and Polarization on Brain Injury After Stroke	45
Middle Meningeal Artery Embolization in Chronic Subdural Hematoma: Implications of Pathophysiology in Trial Design	45
Considerations for Studying Sex as a Biological Variable in Spinal Cord Injury	44
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)	44
Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings	44
Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients	43
Temporal Lobe Epilepsy and Psychiatric Comorbidity	43
Cerebral Vessels: An Overview of Anatomy, Physiology, and Role in the Drainage of Fluids and Solutes	43
Advanced Imaging of Brain Metastases: From Augmenting Visualization and Improving Diagnosis to Evaluating Treatment Response	43
Much More Than a Cytoskeletal Protein: Physiological and Pathological Functions of the Non-microtubule Binding Region of Tau	43
Seizure Forecasting Using a Novel Sub-Scalp Ultra-Long Term EEG Monitoring System	42
Comparison of Transfer Learning and Conventional Machine Learning Applied to Structural Brain MRI for the Early Diagnosis and Prognosis of Alzheimer's Disease	42
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases	42
Subjective Cognitive Decline and Related Cognitive Deficits	42
The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)	42
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke	42
Effect of Conscious Sedation vs. General Anesthesia on Outcomes in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke: A Prospective Randomized Clinical Trial	41
Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease	41
Intracranial Pseudoaneurysms: Evaluation and Management	41
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry	41
Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease	40
Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison	40
A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome — A Report on the Clinical Presentations of the First 100 Patients	40
Superior Longitudinal Fasciculus: A Review of the Anatomical Descriptions With Functional Correlates	40
Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review	40
COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review	40
Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations	40
Astrocyte Glutamate Uptake and Signaling as Novel Targets for Antiepileptogenic Therapy	40
Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases	40
Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements	40
Tremor Syndromes: An Updated Review	39
Abnormal Sleep, Circadian Rhythm Disruption, and Delirium in the ICU: Are They Related?	39
Associations Between White Matter Hyperintensity Burden, Cerebral Blood Flow and Transit Time in Small Vessel Disease: An Updated Meta-Analysis	39
Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders	39
A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders	39
Cognitive Function in Genetic Generalized Epilepsies: Insights From Neuropsychology and Neuroimaging	39
Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses	38
Cognitive Telerehabilitation for Older Adults With Neurodegenerative Diseases in the COVID-19 Era: A Perspective Study	38
Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis	38
Inflammatory Cytokines Associate With Neuroimaging After Acute Mild Traumatic Brain Injury	38
Telemedicine and Virtual Reality at Time of COVID-19 Pandemic: An Overview for Future Perspectives in Neurorehabilitation	38
COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management	38
Blood–Brain Barrier Disruption and Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis	38
Fluorescence-Guided Surgery: A Review on Timing and Use in Brain Tumor Surgery	38
Head-Down Tilt Bed Rest Studies as a Terrestrial Analog for Spaceflight Associated Neuro-Ocular Syndrome	37
Triage of Acute Ischemic Stroke in Confirmed COVID-19: Large Vessel Occlusion Associated With Coronavirus Infection	37
Neurobiological After-Effects of Low Intensity Transcranial Electric Stimulation of the Human Nervous System: From Basic Mechanisms to Metaplasticity	37
A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis	37
Sleep Inconsistency and Markers of Inflammation	37

Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies	37
Functional Outcome Prediction in Ischemic Stroke: A Comparison of Machine Learning Algorithms and Regression Models	37
Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic	37
Astrocytes in Tauopathies	37
MuSK-Associated Myasthenia Gravis: Clinical Features and Management	37
Prognostic Nutritional Index for Predicting 3-Month Outcomes in Ischemic Stroke Patients Undergoing Thrombolysis	36
Enhancing Brain Plasticity to Promote Stroke Recovery	36
Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy	36
What Does Immunology Have to Do With Normal Brain Development and the Pathophysiology Underlying Tourette Syndrome and Related Neuropsychiatric Disorders?	36
Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients	36
Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway	35
Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience	35
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report	35
Acute Hemorrhagic Leukoencephalitis: A Case and Systematic Review of the Literature	35
Epilepsy Occurrence and Circadian Rhythm: A Bibliometrics Study and Visualization Analysis via CiteSpace	35
Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis	35
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex	35
SeXX Matters in Multiple Sclerosis	35
Surface Electromyography Applied to Gait Analysis: How to Improve Its Impact in Clinics?	35
COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention	35
Epilepsy and Its Interaction With Sleep and Circadian Rhythm	35
Management of Juvenile Myasthenia Gravis	35
Which Method for Diagnosing Small Fiber Neuropathy?	35
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis	35
Cerebral Near Infrared Spectroscopy Monitoring in Term Infants With Hypoxic Ischemic Encephalopathy—A Systematic Review	35
Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts	35
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19	35
Guillain–Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases	34
Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke	34
Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases	34
Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy	34
Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management	34
Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature	34
Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome	34
Machine Learning for Diagnosis of AD and Prediction of MCI Progression From Brain MRI Using Brain Anatomical Analysis Using Diffeomorphic Deformation	34
Involvement of CXCL1/CXCR2 During Microglia Activation Following Inflammation-Sensitized Hypoxic-Ischemic Brain Injury in Neonatal Rats	34
Responsive Vagus Nerve Stimulation for Drug Resistant Epilepsy: A Review of New Features and Practical Guidance for Advanced Practice Providers	34
RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability	34
Reductions in Hospital Admissions and Delays in Acute Stroke Care During the Pandemic of COVID-19	34
Case Report: Responsive Neurostimulation of the Centromedian Thalamic Nucleus for the Detection and Treatment of Seizures in Pediatric Primary Generalized Epilepsy	33
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients	33
Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer	33
Forecasting Seizure Likelihood With Wearable Technology	33
In-Silico Trials for Treatment of Acute Ischemic Stroke	33
Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report	33
Impact of COVID-19 on the Speech and Language Therapy Profession and Their Patients	33
Beyond Metabolism: The Complex Interplay Between Dietary Phytoestrogens, Gut Bacteria, and Cells of Nervous and Immune Systems	33
Telemedicine Guidelines in South East Asia—A Scoping Review	33
The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease	33
Botulinum Neurotoxin for the Treatment of Neuropathic Pain	33
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies	33
The Clinical Value of 18F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody	33
Pain and the Triple Network Model	33
Biofeedback for Post-stroke Gait Retraining: A Review of Current Evidence and Future Research Directions in the Context of Emerging Technologies	33
Imaging the Pathophysiology of Essential Tremor—A Systematic Review	32
Motivational Strategies for Stroke Rehabilitation: A Descriptive Cross-Sectional Study	32
Navigated Transcranial Magnetic Stimulation Motor Mapping Usefulness in the Surgical Management of Patients Affected by Brain Tumors in Eloquent Areas: A Systematic Review and Meta-Analysis	32
Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts	32
Migraine Symptoms Improvement During the COVID-19 Lockdown in a Cohort of Children and Adolescents	32
Perilymphatic Fistula: A Review of Classification, Etiology, Diagnosis, and Treatment	32
Ablation of GSDMD Improves Outcome of Ischemic Stroke Through Blocking Canonical and Non-canonical Inflammasomes Dependent Pyroptosis in Microglia	32
A Virtual, Randomized, Control Trial of a Digital Therapeutic for Speech, Language, and Cognitive Intervention in Post-stroke Persons With Aphasia	32
Bioinformatics Identification of Ferroptosis-Related Biomarkers and Therapeutic Compounds in Ischemic Stroke	32
Rupture Risk Assessment for Cerebral Aneurysm Using Interpretable Machine Learning on Multidimensional Data	32
Technology-Enabled Care: Integrating Multidisciplinary Care in Parkinson's Disease Through Digital Technology	32
Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder	32
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data	32
Voice in Parkinson's Disease: A Machine Learning Study	31
Stimulation Mapping Using Stereoelectroencephalography: Current and Future Directions	31
Technical Features, Feasibility, and Acceptability of Augmented Telerehabilitation in Post-stroke Aphasia—Experiences From a Randomized Controlled Trial	31
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)	31
Cerebral Functional Manipulation of Repetitive Transcranial Magnetic Stimulation in Cognitive Impairment Patients After Stroke: An fMRI Study	31
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target	31
Clinical Characteristics of Anti-GABA-B Receptor Encephalitis	31
Repetitive Transcranial Magnetic Stimulation at Different Sites for Dysphagia After Stroke: A Randomized, Observer-Blind Clinical Trial	31
Evaluation of an Immunomodulatory Probiotic Intervention for Veterans With Co-occurring Mild Traumatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study	31
Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults	31
Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome	31
Psychogenic Non-epileptic Seizures and Pseudo-Refractory Epilepsy, a Management Challenge	31
Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis	31
Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	31
Neuropsychiatric or Behavioral and Psychological Symptoms of Dementia (BPSD): Focus on Prevalence and Natural History in Alzheimer's Disease and Frontotemporal Dementia	30
Epileptic Seizure Detection and Experimental Treatment: A Review	30
The Effect of Robotic Assisted Gait Training With Lokomat® on Balance Control After Stroke: Systematic Review and Meta-Analysis	30
Altered Resting-State Functional Connectivity of Multiple Networks and Disrupted Correlation With Executive Function in Major Depressive Disorder	30
Immunotherapies for Neurodegenerative Diseases	30
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis	30
Differences Changes in Cerebellar Functional Connectivity Between Mild Cognitive Impairment and Alzheimer's Disease: A Seed-Based Approach	30
Artifact Reduction in Simultaneous EEG-fMRI: A Systematic Review of Methods and Contemporary Usage	30
Transcutaneous Auricular Vagal Nerve Stimulation and Disorders of Consciousness: A Hypothesis for Mechanisms of Action	30
Leukocyte Counts and Ratios Are Predictive of Stroke Outcome and Hemorrhagic Complications Independently of Infections	30
Understanding the Link Between Allergy and Neurodevelopmental Disorders: A Current Review of Factors and Mechanisms	30
APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease	30
Mechanical Thrombectomy in Isolated Occlusion of the Proximal Posterior Cerebral Artery	30
The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury	30